These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8431356)

  • 41. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy cytotoxicity of human MCF-7 and MDA-MB 231 breast cancer cells is altered by osteoblast-derived growth factors.
    Koutsilieris M; Reyes-Moreno C; Choki I; Sourla A; Doillon C; Pavlidis N
    Mol Med; 1999 Feb; 5(2):86-97. PubMed ID: 10203574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiproliferative effects of suramin on androgen responsive tumour cells.
    Berns EM; Schuurmans AL; Bolt J; Lamb DJ; Foekens JA; Mulder E
    Eur J Cancer; 1990 Apr; 26(4):470-4. PubMed ID: 2141513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.
    Benini S; Manara MC; Baldini N; Cerisano V; Massimo Serra ; Mercuri M; Lollini PL; Nanni P; Picci P; Scotlandi K
    Clin Cancer Res; 2001 Jun; 7(6):1790-7. PubMed ID: 11410521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
    Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D
    J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivo.
    Morris AD; Léonce S; Guilbaud N; Tucker GC; Pérez V; Jan M; Cordi AA; Pierré A; Atassi G
    Anticancer Drugs; 1997 Sep; 8(8):746-55. PubMed ID: 9396618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism.
    Rago R; Mitchen J; Cheng AL; Oberley T; Wilding G
    Cancer Res; 1991 Dec; 51(24):6629-35. PubMed ID: 1742736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines.
    Lokshin A; Peng X; Campbell PG; Barsouk A; Levitt ML
    Cancer Chemother Pharmacol; 1999; 43(4):341-7. PubMed ID: 10071987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media.
    Pratt SE; Pollak MN
    Cancer Res; 1993 Nov; 53(21):5193-8. PubMed ID: 7693333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
    Karey KP; Sirbasku DA
    Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chalcone inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis.
    Hsu YL; Kuo PL; Tzeng WS; Lin CC
    Food Chem Toxicol; 2006 May; 44(5):704-13. PubMed ID: 16307839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sodium phenylacetate (NaPa) induces modifications of the proliferation, the adhesion and the cell cycle of tumoral epithelial breast cells.
    Thibout D; Kraemer M; Di Benedetto M; Saffar L; Gattegno L; Derbin C; Crépin M
    Anticancer Res; 1999; 19(3A):2121-6. PubMed ID: 10470159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suramin inhibits not only tumor growth and metastasis but also angiogenesis in experimental pancreatic cancer.
    Bhargava S; Hotz B; Hines OJ; Reber HA; Buhr HJ; Hotz HG
    J Gastrointest Surg; 2007 Feb; 11(2):171-8. PubMed ID: 17390169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K; Su J; Trovitch PB
    J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of ceramide in suramin-induced cancer cell death.
    Gill JS; Windebank AJ
    Cancer Lett; 1997 Nov; 119(2):169-76. PubMed ID: 9570368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells.
    Kraft A; Reid LM; Zvibel I
    Cancer Res; 1993 Feb; 53(3):652-7. PubMed ID: 8381048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oestrogen causes G2/M arrest and apoptosis in breast cancer cells MDA-MB-231.
    Nomoto S; Arao Y; Horiguchi H; Ikeda K; Kayama F
    Oncol Rep; 2002; 9(4):773-6. PubMed ID: 12066207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melatonin does not inhibit estradiol-stimulated proliferation in MCF-7 and BG-1 cells.
    Baldwin WS; Travlos GS; Risinger JI; Barrett JC
    Carcinogenesis; 1998 Nov; 19(11):1895-900. PubMed ID: 9854999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphine Can Inhibit the Growth of Breast Cancer MCF-7 Cells by Arresting the Cell Cycle and Inducing Apoptosis.
    Chen Y; Qin Y; Li L; Chen J; Zhang X; Xie Y
    Biol Pharm Bull; 2017 Oct; 40(10):1686-1692. PubMed ID: 28740043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.